106
Views
1
CrossRef citations to date
0
Altmetric
Original Research

COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 3027-3034 | Published online: 27 Oct 2021

References

  • World Health Organization. WHO Coronavirus (COVID-19) dashboard; 2021. Available from: https://covid19.who.int/. Accessed September 21, 2021.
  • Zhou Q, Gao Y, Wang X, et al. Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis. Ann Trans Med. 2020;8(10):629. doi:10.21037/atm-20-3324
  • Du Q, Zhang D, Hu W, et al. Nosocomial infection of COVID‑19: a new challenge for healthcare professionals. Int J Mol Med. 2021;47(4):1. doi:10.3892/ijmm.2021.4864.
  • Lechien JR, Chiesa-Estomba CM, Place S, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020;288(3):335–344. doi:10.1111/joim.13089
  • Li R, Tian J, Yang F, et al. Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China. J Clin Virol. 2020;127:104363. doi:10.1016/j.jcv.2020.104363
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
  • Popov GT, Baymakova M, Vaseva V, Kundurzhiev T, Mutafchiyski V. Clinical characteristics of hospitalized patients with COVID-19 in Sofia, Bulgaria. Vector Borne Zoonotic Dis. 2020;20(12):910–915. doi:10.1089/vbz.2020.2679
  • Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi:10.1111/all.14238
  • Ishii T, Kushimoto S, Katori Y, et al. Predictors of SARS-CoV-2 positivity based on RT-PCR Swab Tests at a drive-through outpatient clinic for COVID-19 screening in Japan. Tohoku J Exp Med. 2021;253(2):101–108. doi:10.1620/tjem.253.101
  • Huang T, Guo Y, Li S, et al. Application and effects of fever screening system in the prevention of nosocomial infection in the only designated hospital of coronavirus disease 2019 (COVID-19) in Shenzhen, China. Infect Control Hosp Epidemiol. 2020;41(8):978–981. doi:10.1017/ice.2020.119
  • Anschau F, Worm PV, Kopittke L, et al. Smart Check - COVID-19 triage system: evaluation of the impact on the screening time and identification of clinical manifestations of SARS-CoV-2 infection in a public health service. Int J Clin Pract. 2021:e14610. doi:10.1111/ijcp.14610
  • Stacevičienė I, Burokienė S, Steponavičienė A, Vaičiūnienė D, Jankauskienė A. A cross-sectional study of screening for coronavirus disease 2019 (COVID-19) at the pediatric emergency department in Vilnius during the first wave of the pandemic. Eur J Pediatr. 2021;180(7):2137–2145. doi:10.1007/s00431-021-03999-z
  • Soltan AAS, Kouchaki S, Zhu T, et al. Rapid triage for COVID-19 using routine clinical data for patients attending hospital: development and prospective validation of an artificial intelligence screening test. Lancet Digit Health. 2021;3(2):e78–e87. doi:10.1016/S2589-7500(20)30274-0
  • Peng L, Liu KY, Xue F, Miao YF, Tu PA, Zhou C. Improved early recognition of Coronavirus disease-2019 (COVID-19): single-center data from a Shanghai Screening Hospital. Arch Iran Med. 2020;23(4):272–276.
  • Trahan MJ, Mitric C, Malhamé I, Abenhaim HA. Screening and testing pregnant patients for SARS-CoV-2: first-wave experience of a designated COVID-19 hospitalization centre in Montréal. J Obstet Gynaecol Can. 2021;43(5):571–575.
  • Kuzan TY, Murzoğlu Altıntoprak K, Çiftçi H, et al. A comparison of clinical, laboratory and chest CT findings of laboratory-confirmed and clinically diagnosed COVID-19 patients at first admission. Diagn Interv Radiol. 2021;27(3):336–343. doi:10.5152/dir.2020.20270
  • Stessel B, Callebaut I, Polus F, et al. Evaluation of a comprehensive pre-procedural screening protocol for COVID-19 in times of a high SARS CoV-2 prevalence: a prospective cross-sectional study. Ann Med. 2021;53(1):337–344. doi:10.1080/07853890.2021.1878272
  • Sharma S, Wazir S, Kumar RK. Universal screening for SARS-CoV-2 in asymptomatic pregnant women: a multi-center experience. J Obstet Gynaecol India. 2021;71(suppl 1):1–4.
  • Jung J, Kim J, Lim JS, Kim EO, Kim MN, Kim SH. Pitfall of universal pre-admission screening for SARS-CoV-2 in a low prevalence country. Viruses. 2021;13(5):804. doi:10.3390/v13050804
  • Salaouatchi MT, Mahadeb B, Clevenbergh P, et al. Efficacy of systematic coronavirus screening by PCR and viral cultures in addition to triage in limiting the spread of SARS-CoV-2 within a hemodialysis unit. J Nephrol. 2021:1–8. doi:10.1007/s40620-021-01115-w
  • Storey B, Bottomley M, Hammad S, et al. Regular RNA screening detects asymptomatic SARS-CoV-2 infection in haemodialysis patients. Nephrol Dial Transplant. 2021;36(6):1130–1132. doi:10.1093/ndt/gfab044
  • Al-Shamsi HO, Coomes EA, Alrawi S. Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates. JAMA Oncol. 2020;6(10):1627–1628. doi:10.1001/jamaoncol.2020.2548
  • Wang SM, Tao F, Hou Y, et al. Screening of SARS-CoV-2 in 299 hospitalized children with hemato-oncological diseases: a multicenter survey in Hubei, China. Curr Med Sci. 2020;40(4):642–645. doi:10.1007/s11596-020-2228-7
  • Fujiwara Y, Sato Y, Wang X, et al. Screening for COVID-19 in symptomatic cancer patients in a cancer hospital. Cancer Cell. 2020;38(5):609–610. doi:10.1016/j.ccell.2020.09.017
  • Chang E, Choi JS, Park TY, et al. A universal screening strategy for SARS-CoV-2 infection in intensive care units: Korean experience in a single hospital. Infect Chemother. 2020;52(3):352–359. doi:10.3947/ic.2020.52.3.352
  • Wee LE, Conceicao EP, Aung MK, et al. Rostered routine testing for healthcare workers and universal inpatient screening: the role of expanded hospital surveillance during an outbreak of COVID-19 in the surrounding community. Infect Control Hosp Epidemiol. 2021;1–9. doi:10.1017/ice.2021.366
  • Saidel-Odes L, Shafat T, Nativ R, Borer A, Nesher L. SARS-CoV-2 universal screening upon adult hospital admission in Southern Israel. J Hosp Infect. 2021;114:167–170. doi:10.1016/j.jhin.2021.04.026
  • Alsuhaibani MA, Kobayashi T, Trannel A, et al. Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020. Infect Control Hosp Epidemiol. 2021:1–5. doi:10.1017/ice.2021.294
  • Krüger S, Leskien M, Schuller P, et al. Performance and feasibility of universal PCR admission screening for SARS-CoV-2 in a German tertiary care hospital. J Med Virol. 2021;93(5):2890–2898. doi:10.1002/jmv.26770
  • Scheier T, Schibli A, Eich G, et al. Universal admission screening for SARS-CoV-2 infections among hospitalized patients, Switzerland, 2020. Emerg Infect Dis. 2021;27(2):404–410. doi:10.3201/eid2702.202318
  • Uchida S, Uwamino Y, Uno S, et al. Universal polymerase chain reaction screening for severe Acute Respiratory Syndrome Coronavirus 2 in asymptomatic patients before hospital admission in Tokyo, Japan. J Clin Virol. 2021;142:104915. doi:10.1016/j.jcv.2021.104915
  • Stadler RN, Maurer L, Aguilar-Bultet L, et al. Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections. Antimicrob Resist Infect Control. 2021;10(1):44. doi:10.1186/s13756-021-00912-z
  • Ayenigbara IO, Adeleke OR, Ayenigbara GO, Adegboro JS, Olofintuyi OO. COVID-19 (SARS-CoV-2) pandemic: fears, facts and preventive measures. Germs. 2020;10(4):218–228. doi:10.18683/germs.2020.1208
  • Arefi MF, Poursadeqiyan M. A review of studies on the COVID-19 epidemic crisis disease with a preventive approach. Work. 2020;66(4):717–729.
  • Rosolanka R, Henao-Martinez AF, Pisney L, Franco-Paredes C, Krsak M. COVID-19: a review of current knowledge regarding exposure, quarantine, isolation and other preventive measures. Ther Adv Infect Dis. 2021;8:20499361211032039. doi:10.1177/20499361211032039
  • Abbas M, Robalo Nunes T, Martischang R, et al. Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers. Antimicrob Resist Infect Control. 2021;10(1):7. doi:10.1186/s13756-020-00875-7
  • Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020;52(2):154–164. doi:10.3947/ic.2020.52.2.154
  • Liu Z, Chu R, Gong L, Su B, Wu J. The assessment of transmission efficiency and latent infection period in asymptomatic carriers of SARS-CoV-2 infection. Int J Infect Dis. 2020;99:325–327. doi:10.1016/j.ijid.2020.06.036
  • Gupta P, Muthukumar N, Rajshekhar V, et al. Neurosurgery and neurology practices during the Novel COVID-19 pandemic: a consensus statement from India. Neurol India. 2020;68(2):246–254. doi:10.4103/0028-3886.283130
  • Arimappamagan A, Vilanilam G, Pandey P. Is elective neurosurgery justified during COVID-19 pandemic? Neurol India. 2021;69(1):21–25. doi:10.4103/0028-3886.310113
  • Tsermoulas G, Zisakis A, Flint G, Belli A. Challenges to neurosurgery during the Coronavirus disease 2019 (COVID-19) pandemic. World Neurosurg. 2020;139:519–525. doi:10.1016/j.wneu.2020.05.108
  • Agarwal N, Raheja A, Suri A. Guidelines for preoperative testing for neurosurgery in Coronavirus disease 2019 (COVID-19) era: Indian viewpoint amidst global practice. World Neurosurg. 2021;146:103–112. doi:10.1016/j.wneu.2020.10.086
  • Shaheen S, Awwad O, Shokry K, et al. Rapid guide to the management of cardiac patients during the COVID-19 pandemic in Egypt: “a position statement of the Egyptian Society of Cardiology”. Egypt Heart J. 2020;72(1):30.
  • Harky A, Chor CYT, Khare Y. COVID-19 and its impact on cardiology service. Acta Biomed. 2020;91(4). doi:10.1136/openhrt-2020-001359
  • Sahu A, Kapoor A. Guiding principles for cardiology care in times of the COVID-19 pandemic: gazing through the crystal ball. Ann Card Anaesth. 2020;23(4):532–536. doi:10.4103/aca.ACA_150_20
  • Yasmin F, Shujauddin SM, Naeem A, et al. Exploring the impact of the COVID-19 pandemic on provision of cardiology services: a scoping review. Rev Cardiovasc Med. 2021;22(1):83–95. doi:10.31083/j.rcm.2021.01.241
  • Anker SD, Butler J, Khan MS, et al. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an expert consensus position paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2020;41(22):2109–2117. doi:10.1093/eurheartj/ehaa461
  • Zhang Y, Coats AJS, Zheng Z, et al. Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22(6):941–956. doi:10.1002/ejhf.1915
  • Lin KC, Wang CC, Huang WC, Hwang JJ. Considerations when managing heart failure during the COVID-19 pandemic-consensus from the Taiwan Society of Cardiology. Acta Cardiol Sin. 2021;37(2):125–129.
  • Garg N, McClafferty B, Ramgobin D, Golamari R, Jain R, Jain R. Cardiology and COVID-19: do we have sufficient information? Future Cardiol. 2021;17(4):705–711. doi:10.2217/fca-2020-0126